-
Structural Insights into the Nipah Virus L-P Polymerase Comp
2026-04-30
This study presents high-resolution structures of the Nipah virus polymerase complex, clarifying the molecular interactions essential for viral RNA synthesis. The findings reveal mechanistic details that can inform future antiviral drug development targeting the polymerase machinery.
-
One-step TUNEL FITC Apoptosis Detection Kit: Precision in DN
2026-04-30
The One-step TUNEL FITC Apoptosis Detection Kit empowers researchers to sensitively and reproducibly detect apoptosis in both tissue sections and cultured cells. Its streamlined workflow and FITC-labeled dUTP incorporation technology accelerate experimental throughput, while advanced troubleshooting guidance ensures robust, quantitative results in cancer and vascular research models.
-
Lopinavir Identified as an Inhibitor of MERS-CoV Replication
2026-04-29
de Wilde et al. systematically screened FDA-approved compounds and identified Lopinavir (ABT-378) as one of four small molecules capable of inhibiting Middle East respiratory syndrome coronavirus (MERS-CoV) replication in cell culture. This work highlights the translational potential of repurposing HIV protease inhibitors for emerging coronavirus threats and offers a starting point for future antiviral research.
-
Photothermal Therapy and CD47 Blockade Synergy in OSCC
2026-04-29
This study demonstrates that combining photothermal therapy (PTT) with CD47 blockade in oral squamous cell carcinoma (OSCC) induces immunogenic cell death and remodels the tumor extracellular matrix, greatly enhancing macrophage-mediated anti-tumor responses. These findings clarify mechanisms underlying improved immunotherapy efficacy and provide a preclinical rationale for integrating PTT with immune checkpoint strategies in solid tumors.
-
Lopinavir (ABT-378): Redefining HIV Protease Research Precis
2026-04-28
Explore how Lopinavir (ABT-378) sets a new benchmark in HIV protease inhibition and resistance studies. This in-depth article unveils advanced assay design, translational insights, and practical guidance for next-generation antiviral research.
-
Connexin 43–NF-κB Axis Drives AngII-Induced Macrophage Polar
2026-04-28
This study elucidates a mechanistic pathway by which angiotensin II induces pro-inflammatory M1 polarization in RAW264.7 macrophages through upregulation of connexin 43 and activation of NF-κB p65 signaling. The findings clarify the role of gap junction communication in immune modulation, offering experimental rationale for targeting connexin 43 hemichannels to influence macrophage-driven inflammation.
-
Protease Inhibitor Cocktail: Enhancing Protein Stability in
2026-04-27
The Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) stands out as a protein stability enhancer, safeguarding labile protein complexes during challenging cell and tissue extraction workflows. Its optimized inhibitor spectrum, including EDTA, ensures reliable preservation of regulatory proteins like DFCP1 and ATGL during the analysis of lipid droplet metabolism.
-
S-Adenosylhomocysteine: Precision Tool for Methylation Cycle
2026-04-27
S-Adenosylhomocysteine (SAH) empowers researchers to dissect methylation dynamics, modulate the SAM/SAH ratio, and model disease-relevant metabolic states with confidence. APExBIO’s SAH (SKU B6123) offers robust solubility and reproducible performance, enabling advanced workflows in epigenetics, neurobiology, and cystathionine β-synthase deficiency research.
-
Dual-Reporter Cy5-labeled mRNA: Mechanistic Insights and Nex
2026-04-26
Explore the mechanistic innovations and assay design advantages of EZ Cap™ Cy5 EGFP mRNA (5-moUTP), a Cy5-labeled mRNA enabling real-time visualization and analysis of gene delivery. This article uniquely unpacks advanced nanoparticle assembly and practical workflow implications for translational research.
-
Cy3 TSA Fluorescence System Kit: Amplifying IHC & ICC Sensit
2026-04-25
The Cy3 TSA Fluorescence System Kit redefines immunohistochemistry and immunocytochemistry workflows, enabling reliable detection of low-abundance biomolecules. Explore stepwise optimizations, protocol-driven troubleshooting, and translational insights from cutting-edge olfactory research—empowering researchers to achieve robust, high-fidelity fluorescence signals.
-
Spermine Tetrahydrochloride: Precision Workflows in Bench Bi
2026-04-24
Spermine tetrahydrochloride, a highly water-soluble polyamine, empowers researchers with robust membrane stabilization, protein crystallization, and advanced nanoparticle crosslinking. Its unique charge-based mechanisms offer reproducibility and efficiency across protoplast, neuroscience NMDA receptor, and polymer formulation assays—outperforming related polyamines in critical experiments.
-
Lopinavir (ABT-378): Optimizing HIV Protease Inhibition Assa
2026-04-24
Lopinavir (ABT-378) redefines HIV protease inhibition with nanomolar potency and remarkable serum stability, outperforming earlier inhibitors and enabling precise resistance and efficacy studies. This article delivers practical workflows, troubleshooting guidance, and cross-pathogen applications, positioning APExBIO’s Lopinavir as the benchmark compound for cutting-edge antiviral research.
-
Senolytic Elimination of Glioblastoma Cells Post-TMZ: SCAP I
2026-04-23
This study reveals that senescent glioblastoma cells, which evade apoptosis after temozolomide (TMZ) treatment, can be effectively targeted by inhibiting antiapoptotic factors c-IAP2 and Bcl-2. The findings suggest a new therapeutic route for enhancing the efficacy of TMZ-based regimens by selectively eliminating therapy-resistant senescent tumor cells.
-
A40926: Glycopeptide Antibiotic with Distinct Anti-Neisseria
2026-04-23
The reference study identifies A40926 as a novel glycopeptide antibiotic complex with potent activity against Gram-positive bacteria and, uniquely, Neisseria gonorrhoeae. Its structural features and robust activity profile suggest research value for antibiotic development and resistance studies, especially where conventional agents face limitations.
-
(S)-(+)-Ibuprofen: Selective COX Inhibitor for Inflammation
2026-04-22
(S)-(+)-Ibuprofen is a potent, selective COX inhibitor used in inflammation pathway research and pain mechanism studies. Its enantiomeric purity provides reproducible results and fewer side effects compared to the R-form. The B1018 kit from APExBIO delivers high-quality material for cell and animal assays.